Speciality Podcast - Pain Podcast
Professor McInnes reviews key abstract from ACR 2…
Listen to this episode
Summary
Professor McInnes reviews key abstract from ACR 2018, relating to pain and JAK inhibitors.
First published
04/10/2019
Genres
Duration
12 minutes
Parent Podcast
The IMID Forum
View PodcastSimilar Episodes
-
IMID Author Interview: Dorthe Berthelsen, 2024
Release Date: 05/14/2024
Description: Join Professor Peter Nash from the Griffith University in Brisbane, and Dorthe Berthelsen, a PhD student and physiotherapist at the Parker Institute in Copenhagen and at the University of Southern Denmark, as they discuss her recent paper ‘“I couldn't carry on taking a drug like that”: A qualitative study of patient perspectives on side effects from rheumatology drugs.’
Explicit: No
-
IMID Author Interview: Dr Jake Weddell, 2024
Release Date: 05/07/2024
Description: Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Jake Weddell, an academic rheumatology trainee at Leeds Teaching Hospitals NHS Trust, as they discuss his recent paper ‘Real-world experience of IL-17Ai drug survival in a large cohort of axial spondyloarthritis and psoriatic arthritis.’
Explicit: No
-
IMID Author Interview: Professor Frank Verhoeven, 2024
Release Date: 04/30/2024
Description: Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Frank Verhoeven, an Assistant Professor in Rheumatology at the CHU Besancon in France, as they discuss his recent paper ‘Effects of disease‑modifying anti‑rheumatic drugs on sacroiliac MRI score in axial spondyloarthritis: A systematic review and meta‑analysis.’
Explicit: No
-
IMID Author Interview: Dr Blanca Hernández-Cruz, 2024
Release Date: 05/28/2024
Description: Join Professor Peter Nash from the Griffith University in Brisbane, and Blanca Hernández-Cruz, a rheumatologist at Virgen Macarena University Hospital in Seville, as they discuss her recent paper ‘Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry’.
Explicit: No
Comments
Sign in to leave a comment.
No comments yet. Be the first to comment!